Takeda’s Q1 Sales Up 2.4% Despite Diabetes Divesture Last Year, Gets Hefty FX Gains

July 29, 2022
Takeda Pharmaceutical’s April-June revenue ticked up 2.4% year on year on the back of its strong business momentum and foreign exchange gains, which more than countered a pullback from its one-time income a year ago tied to the divestiture of...read more